Determination of ebrotidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography
- 10 January 1997
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 688 (1) , 107-115
- https://doi.org/10.1016/s0378-4347(97)88062-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Metabolites of Ebrotidine, a New hfe-Receptor Antagonist, in Human UrineJournal of Pharmaceutical Sciences, 1994
- Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanolGeneral Pharmacology: The Vascular System, 1992
- Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pyloriGeneral Pharmacology: The Vascular System, 1992
- Pharmacokinetic and Pharmacodynamic Properties of Histamine H2-Receptor AntagonistsClinical Pharmacokinetics, 1991
- Simultaneous determination of ranitidine and its metabolites in human plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Inhibitors of gastric acid secretion: N-sulphonyl formamidines in a series of new histamine H2-receptor antagonistsEuropean Journal of Medicinal Chemistry, 1988
- Highly sensitive determination of cimetidine and its metabolites in serum and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Comparison of two high-performance liquid chromatographic methods for the determination of oxmetidine and its metabolites in plasma, bile and urine samplesJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- The metabolism of [14C]cimetidine in manXenobiotica, 1982
- Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981